NGF – Pioneering Preventive Neuromedicine & Neurotheranostics
NGF – Pioneering Preventive Neuromedicine & Neurotheranostics
NGF's is developing a brain-organoid platform to revolutionize drug screening and personalized neuromedicine. Founding team is a group of experienced bio scientists collaborating with Singapore government agency A-Stars to pioneer preventive neuromedicine and neurotheranostics. Scheduled to list on Canadia TSX in Feb and planning to go US Nasdaq at appropriate time soon.